2020-05-04
|
R-HSA-9656207
|
CR2 RAF1 mutants don't bind YWHAB
|
BibTex
|
2020-05-04
|
R-HSA-9656209
|
Dissociation of RAS:RAF1 mutant complex
|
BibTex
|
2020-05-04
|
R-HSA-9656214
|
MAP2Ks phosphorylate MAPKs downstream of RAF1 mutants
|
BibTex
|
2020-05-04
|
R-HSA-9656215
|
RAF1 mutant complexes phosphorylate MAP2K dimer
|
BibTex
|
2020-05-04
|
R-HSA-9656211
|
MAP2Ks and MAPKs bind to the activated mutant RAF1 complex
|
BibTex
|
2020-05-04
|
R-HSA-9656212
|
Phosphorylation of RAF1 mutants
|
BibTex
|
2020-05-04
|
R-HSA-9658253
|
RAS:GTP binds PI3K
|
BibTex
|
2020-05-04
|
R-HSA-9647978
|
pro-RAS proteins are farnesylated
|
BibTex
|
2020-05-04
|
R-HSA-9647999
|
RCE1 cleaves S-Farn proRAS proteins
|
BibTex
|
2020-05-04
|
R-HSA-9647977
|
ICMT methylates S-Farn RAS proteins
|
BibTex
|
2020-05-04
|
R-HSA-9649732
|
Mature S-Farn-Me KRAS4B translocates to plasma membrane
|
BibTex
|
2020-05-04
|
R-HSA-9647982
|
S-farn Me-HRAS, -NRAS and -KRAS4A are palmitoylated
|
BibTex
|
2020-05-04
|
R-HSA-9647980
|
mature RAS proteins translocate to plasma membrane
|
BibTex
|
2020-05-04
|
R-HSA-9649733
|
mature p21 RAS binds GDP
|
BibTex
|
2020-05-04
|
R-HSA-9649735
|
Intrinsic nucleotide exchange on RAS
|
BibTex
|
2020-05-04
|
R-HSA-9649736
|
RAS intrinsic GTPase activity hydrolyzes GTP to GDP
|
BibTex
|
2020-05-04
|
R-HSA-9657599
|
Dual mechanism MAP2K inhibitors bind MAP2Ks
|
BibTex
|
2020-05-04
|
R-HSA-9657603
|
Dual mechanism MAPK inhibitors bind MAPKs
|
BibTex
|
2020-05-04
|
R-HSA-9657608
|
Single mechanism MAPK inhibitors bind phosphorylated MAPK
|
BibTex
|
2020-05-04
|
R-HSA-9657606
|
Single mechanism MAP2K inhibitors bind phosphorylated MAP2Ks
|
BibTex
|
2020-05-04
|
R-HSA-9653503
|
KRAS4B is phosphorylated on serine 181
|
BibTex
|
2020-05-04
|
R-HSA-9653592
|
pS181-S-Farn-Me KRAS4B translocates to the outer mitochondrial membrane
|
BibTex
|
2020-05-04
|
R-HSA-9653585
|
S-Farn-Me KRAS4B binds calmodulin
|
BibTex
|
2020-05-04
|
R-HSA-9654521
|
Calmodulin dissociates KRAS4B from the plasma membrane
|
BibTex
|
2020-05-04
|
R-HSA-9654525
|
PDE6D binds S-Farn-Me KRAS4B:CALM:4 Ca2+
|
BibTex
|
2020-05-04
|
R-HSA-9654523
|
ARL2:GTP bind PDE6D on KRAS4B
|
BibTex
|
2020-05-04
|
R-HSA-9654533
|
KRAS4B recycles to the plasma membrane
|
BibTex
|
2020-05-04
|
R-HSA-9647991
|
Palmostatin B binds RAS depalmitoylases
|
BibTex
|
2020-05-04
|
R-HSA-9653514
|
USP17L2 deubiquitinates RCE1
|
BibTex
|
2020-05-04
|
R-HSA-9647987
|
FNTB inhibitors bind FNTA:FNTB
|
BibTex
|
2020-05-04
|
R-HSA-9647994
|
RAS proteins are depalmitoylated
|
BibTex
|
2020-05-04
|
R-HSA-9653595
|
pS181-S-Farn-Me KRAS4B binds BCL2L1
|
BibTex
|
2020-05-04
|
R-HSA-9656775
|
Cysmethynil binds ICMT:Zn2+
|
BibTex
|
2020-05-04
|
R-HSA-9656781
|
Deltarasin binds PDE6D
|
BibTex
|
2020-05-04
|
R-HSA-8867654
|
PTPN3 binds p-T183,Y185 MAPK12
|
BibTex
|
2020-05-04
|
R-HSA-9635743
|
PTPN7 binds p-T,Y-MAPK
|
BibTex
|
2020-05-04
|
R-HSA-9635739
|
PTPN7 dephosphorylates p-T,Y-MAPKs
|
BibTex
|
2020-05-04
|
R-HSA-8867658
|
PTPN3 dephosphorylates MAPK12
|
BibTex
|
2020-05-04
|
R-HSA-8868118
|
MAPK12 phosphorylates PTPN3
|
BibTex
|
2020-05-04
|
R-HSA-9660557
|
RAS:GTP binds RAL GDS proteins
|
BibTex
|
2020-05-04
|
R-HSA-9653108
|
Raf dimer inhibitors bind RAF heterodimers
|
BibTex
|
2020-05-04
|
R-HSA-9658445
|
MRAS:SHOC2:PPP1CC dephosphorylates inactive RAFs
|
BibTex
|
2020-05-04
|
R-HSA-6802834
|
RAS GTPase mutants don't hydrolyze GTP
|
BibTex
|
2020-05-04
|
R-HSA-9652816
|
Constitutively active MAPK1 mutants are not dephosphorylated by DUSPs
|
BibTex
|
2020-05-04
|
R-HSA-9652165
|
MAP2K mutants constitutively phosphorylate MAPKs
|
BibTex
|
2020-05-04
|
R-HSA-9660536
|
SHOC2 M173I disrupts the SHOC2:MRAS:PP1 complex
|
BibTex
|
2020-05-04
|
R-HSA-9660538
|
Mutant MRAS:SHOC2:PPP1CC complexes dephosphorylate inactive RAFs
|
BibTex
|
2020-05-04
|
R-HSA-9656213
|
RAF1 mutants show enhanced heterodimerization with BRAF
|
BibTex
|